SCHEMBL20406342

SCHEMBL20406342

CC(F)(F)c1ccc(Oc2ncccc2C#C[Si](C)(C)C(C)(C)C)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20406344 0.82 ALDH1A1 (0.34) —
SCHEMBL20406568 0.76 DRD1 (0.38) —
SCHEMBL20406170 0.75 PDE10A (0.39) —
SCHEMBL18661513 0.73 PDE10A (0.42) —
SCHEMBL20406785 0.70 DRD1 (0.38) —
SCHEMBL18661516 0.70 PDE10A (0.45) —
SCHEMBL20394241 0.69 DRD1 (0.37) —
SCHEMBL20394221 0.69 FEN1 (0.39) —
SCHEMBL20394327 0.69 CYP17A1 (0.38) —
SCHEMBL20394326 0.69 SCN9A (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647675-B2 Biaryl derivative and medicine containing same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2020-05-12 — — US disclosed
US-20190055199-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2019-02-21 — — US disclosed
EP-3351533-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME Kaken Pharmaceutical Co., Ltd. (JP) 2018-07-25 — — EP disclosed
Send feedback